stockrowLantheus Holdings, Inc.
LNTH Healthcare Drug Manufacturers Specialty & Generic
Lantheus Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, up 0.50% from fiscal 2024.
- Revenue
- +1.54%
- EPS
- −17.1%
- Free cash flow
- +7.71%
- Total debt
- +0.52%
Quarter to September 2026, against a year earlier
Follow LNTH
Alert me
Lantheus Holdings, Inc. (LNTH) Total debt
Lantheus Holdings, Inc.'s total debt at the end of fiscal 2025 was $569.4M, unchanged from fiscal 2024. At the end of the quarter to 30 September 2026 it was $571.7M. Over the past ten years it has ranged from $174.8M (fiscal 2021) to $569.4M (fiscal 2025) — the current reading is the highest in ten years. Lantheus Holdings, Inc. ranks 18th of 84 Drug Manufacturers Specialty & Generic companies by total debt.
Total debt, annual
Embed this chart
Annual newest first
| Period | Total debt | Change |
|---|---|---|
| FY2025 | $569.4M | 0.56% |
| FY2024 | $566.3M | 0.67% |
| FY2023 | $562.5M | 0.79% |
| FY2022 | $558.1M | 219.33% |
| FY2021 | $174.8M | (19.98%) |
| FY2020 | $218.4M | 12.54% |
| FY2019 | $194.1M | (27.17%) |
| FY2018 | $266.5M | (0.63%) |
| FY2017 | $268.1M | (3.58%) |
| FY2016 | $278.1M | (21.33%) |
Quarterly newest first
| Period | Total debt | Change |
|---|---|---|
| Sep 2026 | $571.7M | 0.12% |
| Jun 2026 | $571.1M | 0.11% |
| Mar 2026 | $570.4M | 0.17% |
| Dec 2025 | $569.4M | 0.11% |
| 42 more quarters | Free account |
Against its own ten years
Total debt against peers
| Company | Total debt |
|---|---|
| AMRX AMNEAL PHARMACEUTICALS, INC. compare | $3.2B |
| ALKS Alkermes plc compare | $1.5B |
| HIMS Hims & Hers Health, Inc. compare | $1.4B |
| RDY Dr. Reddy's Laboratories Ltd compare | $753.0M |
| LNTH Lantheus Holdings, Inc. | $571.7M |
| SUPN Indivior Pharmaceuticals Inc. compare | $488.0M |
| LQDA Liquidia Corporation compare | $176.1M |
| KNSA Kiniksa Pharmaceuticals International, plc compare | $13.0M |
| AMLX Amylyx Pharmaceuticals, Inc. compare | $1.4M |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on LNTH
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement